Literature DB >> 29850954

Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.

Jeffrey E Gershenwald1,2, Richard A Scolyer3,4,5.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29850954     DOI: 10.1245/s10434-018-6513-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  91 in total

Review 1.  Neoadjuvant Immunotherapy for Locally Advanced Melanoma.

Authors:  Meredith S Pelster; Rodabe N Amaria
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

2.  Completely resected stage III melanoma controversy - 15 years of national tertiary centre experience.

Authors:  Barbara Peric; Sara Milicevic; Andraz Perhavec; Marko Hocevar; Janez Zgajnar
Journal:  Radiol Oncol       Date:  2020-10-08       Impact factor: 2.991

3.  Staging for Melanoma - Toward a New Paradigm?

Authors:  David E Elder; Giorgos Karakousis; Richard A Scolyer
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

Review 4.  Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.

Authors:  Douglas Grossman; Nwanneka Okwundu; Edmund K Bartlett; Michael A Marchetti; Megan Othus; Daniel G Coit; Rebecca I Hartman; Sancy A Leachman; Elizabeth G Berry; Larissa Korde; Sandra J Lee; Menashe Bar-Eli; Marianne Berwick; Tawnya Bowles; Elizabeth I Buchbinder; Elizabeth M Burton; Emily Y Chu; Clara Curiel-Lewandrowski; Julia A Curtis; Adil Daud; Dekker C Deacon; Laura K Ferris; Jeffrey E Gershenwald; Kenneth F Grossmann; Siwen Hu-Lieskovan; John Hyngstrom; Joanne M Jeter; Robert L Judson-Torres; Kari L Kendra; Caroline C Kim; John M Kirkwood; David H Lawson; Philip D Leming; Georgina V Long; Ashfaq A Marghoob; Janice M Mehnert; Michael E Ming; Kelly C Nelson; David Polsky; Richard A Scolyer; Eric A Smith; Vernon K Sondak; Mitchell S Stark; Jennifer A Stein; John A Thompson; John F Thompson; Suraj S Venna; Maria L Wei; Susan M Swetter
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

5.  Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.

Authors:  Lauren E Haydu; Serigne N Lo; Jennifer L McQuade; Rodabe N Amaria; Jennifer Wargo; Merrick I Ross; Janice N Cormier; Anthony Lucci; Jeffrey E Lee; Sherise D Ferguson; Robyn P M Saw; Andrew J Spillane; Kerwin F Shannon; Jonathan R Stretch; Patrick Hwu; Sapna P Patel; Adi Diab; Michael K K Wong; Isabella C Glitza Oliva; Hussein Tawbi; Matteo S Carlino; Alexander M Menzies; Georgina V Long; Alexander J Lazar; Michael T Tetzlaff; Richard A Scolyer; Jeffrey E Gershenwald; John F Thompson; Michael A Davies
Journal:  J Clin Oncol       Date:  2020-01-28       Impact factor: 44.544

6.  Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma.

Authors:  Georgia M Beasley
Journal:  Ann Surg Oncol       Date:  2020-04-19       Impact factor: 5.344

Review 7.  Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Authors:  Nika Filipović; Mirna Šitum; Marija Buljan
Journal:  Dermatol Pract Concept       Date:  2021-04-12

8.  Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.

Authors:  Clio Dessinioti; Niki Dimou; Alan C Geller; Aravella Stergiopoulou; Serigne Lo; Ulrike Keim; Jeffrey E Gershenwald; Lauren E Haydu; Simone Ribero; Pietro Quaglino; Susana Puig; Josep Malvehy; Lidija Kandolf-Sekulovic; Tatjana Radevic; Roland Kaufmann; Laura Meister; Eduardo Nagore; Victor Traves; Grigorios G Champsas; Mihaela Plaka; Brigitte Dreno; Emilie Varey; David Moreno Ramirez; Reinhard Dummer; Joanna Mangana; Axel Hauschild; Friederike Egberts; Ketty Peris; Laura Del Regno; Ana-Maria Forsea; Sabina A Zurac; Ricardo Vieira; Ana Brinca; Iris Zalaudek; Teresa Deinlein; Eleni Linos; Evangelos Evangelou; John F Thompson; Richard A Scolyer; Claus Garbe; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

9.  Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.

Authors:  Emily Z Keung; Jeffrey E Gershenwald
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

Review 10.  Injectable Therapies for Regional Melanoma.

Authors:  Norma E Farrow; Margaret Leddy; Karenia Landa; Georgia M Beasley
Journal:  Surg Oncol Clin N Am       Date:  2020-07       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.